Caribou Biosciences, Inc. (CRBU)
NASDAQ: CRBU · Real-Time Price · USD
1.900
-0.040 (-2.06%)
At close: Dec 5, 2025, 4:00 PM EST
1.895
-0.005 (-0.29%)
After-hours: Dec 5, 2025, 7:36 PM EST
Caribou Biosciences Market Cap
Caribou Biosciences has a market cap or net worth of $177.59 million as of December 5, 2025. Its market cap has decreased by -1.34% in one year.
Market Cap
177.59M
Enterprise Value
43.84M
1-Year Change
-1.34%
Ranking
Category
Stock Price
$1.90
Market Cap Chart
Since the IPO on July 23, 2021, Caribou Biosciences's market cap has decreased from $888.48M to $177.59M, a decrease of -80.01%. That is a compound annual growth rate of -30.80%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 5, 2025 | 177.26M | 23.24% |
| Dec 31, 2024 | 143.82M | -71.62% |
| Dec 29, 2023 | 506.72M | 32.27% |
| Dec 30, 2022 | 383.09M | -58.07% |
| Dec 31, 2021 | 913.64M | 2.83% |
| Jul 23, 2021 | 888.48M | - |
View and export this data all the way back to 2021. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 908.36B |
| Johnson & Johnson | 487.83B |
| AbbVie | 404.22B |
| UnitedHealth Group | 302.09B |
| AstraZeneca | 279.81B |
| Novartis AG | 255.73B |
| Merck & Co. | 250.41B |
| Abbott Laboratories | 218.05B |